Current Neuro-Oncology

Volume 22 Number 2
31 January 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 2, 31 January

Schepke E, Tisell M, Kennedy C, Puget S, Ferroli P, Chevignard M, Doz F, Pizer B, Rutkowski S, Massimino M, Navajas A, Schwalbe E, Hicks D, Clifford SC, Pietsch T, Lannering B.
Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 study.
J Neurosurg Pediatr. 2020 Jan 17, 2020;1-9∟. doi: 10.3171/2019.11.PEDS19349∟. PMID: 31952041∟. Interventional study. ˍ

Umphlett M, Shea S, Tome-Garcia J, Zhang Y, Hormigo A, Fowkes M, Tsankova NM, Yong RL.
Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
BMC Cancer. 2020 Jan 20, 2020;20(1):47∟. doi: 10.1186/s12885-020-6540-1∟. PMID: 31959133∟. Case report. ˍ

Grist JT, Withey S, MacPherson L, et al.
Distinguishing between paediatric brain tumour types using multi-parametric magnetic resonance imaging and machine learning: A multi-site study.
Neuroimage Clin. 2020 Jan 23, 2020;25:102172∟. doi:10.1016/j.nicl.2020.102172∟. PMID: 32032817∟. Observational study. ˍ

Kamiya-Matsuoka C, Hamza MA, de Groot JF.
Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma.
J Clin Neurosci. 2020 Jan 23, 2020;S0967-5868(19)32172-1∟. doi: 10.1016/j.jocn.2020.01.066∟. PMID: 31982279∟. Observational study. ˍ

Kessler T, Berberich A, Casalini B, Drüschler K, Ostermann H, Dormann A, Walter S, Hai L, Schlesner M, Herold-Mende C, Jungk C, Unterberg A, Bendszus M, Sahm K, von Deimling A, Winkler F, Platten M, Wick W, Sahm F, Wick A.
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma.
Neurooncol Adv. 2020 Jan 23, 2020;2(1):vdz060∟. doi: 10.1093/noajnl/vdz060∟. PMID: 32642725∟. Observational study. ˍ

Makepeace L, Scoggins M, Mitrea B, Li Y, Edwards A, Tinkle CL, Hwang S, Gajjar A, Patay Z.
MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas.
AJNR Am J Neuroradiol. 2020 Jan 23, 2020;10.3174/ajnr.A6391∟. doi: 10.3174/ajnr.A6391∟. PMID: 31974084∟. Observational study. ˍ

Ottensmeier H, Schlegel PG, Eyrich M, Wolff JE, Juhnke BO, von Hoff K, Frahsek S, Schmidt R, Faldum A, Fleischhack G, von Bueren A, Friedrich C, Resch A, Warmuth-Metz M, Krauss J, Kortmann RD, Bode U, Kühl J, Rutkowski S.
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.
PLoS One. 2020 Jan 23, 2020;15(1):e0227693∟. doi: 10.1371/journal.pone.0227693∟. PMID: 31971950∟. Observational study. ˍ

Schipmann S, Müther M, Stögbauer L, Zimmer S, Brokinkel B, Holling M, Grauer O, Suero Molina E, Warneke N, Stummer W.
Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.
J Neurosurg. 2020 Jan 24, 2020;1-11∟. doi: 10.3171/2019.11.JNS192443∟. PMID: 31978877∟. Observational study. ˍ

Shafer D, Tombes MB, Shrader E, Ryan A, Bandyopadhyay D, Dent P, Malkin M.
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma.
Neurooncol Adv. 2020 Jan 24. 2020;2(1):vdz052∟. doi: 10.1093/noajnl/vdz052∟. PMID: 32642720∟. Interventional study. ˍ

Timme CR, Degorre-Kerbaul C, McAbee JH, Rath BH, Wu X, Camphausen K, Tofilon PJ.
The olfactory bulb provides a radioresistant niche for glioblastoma cells.
Int J Radiat Oncol Biol Phys. 2020 Jan 24, 2020;S0360-3016(20)30066-3∟. doi: 10.1016/j.ijrobp.2020.01.007∟. PMID: 31987963∟. Laboratory investigation. ˍ

Woodroffe RW, Zanaty M, Soni N, Mott SL, Helland LC, Pasha A, Maley J, Dhungana N, Jones KA, Monga V, Greenlee JDW.
Survival after reoperation for recurrent glioblastoma.
J Clin Neurosci. 2020 Jan 24, 2020;S0967-5868(19)31151-8∟. doi: 10.1016/j.jocn.2020.01.009∟. PMID: 31987636∟. Observational study. ˍ

Skjulsvik AJ, Bø HK, Jakola AS, Berntsen EM, Bø LE, Reinertsen I, Myrmel KS, Sjåvik K, Åberg K, Berg T, Dai HY, Kloster R, Torp SH, Solheim O.
Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?
J Neurooncol. 2020 Jan 25, 2020;10.1007/s11060-020-03409-8∟. doi: 10.1007/s11060-020-03409-8∟. PMID: 31983026∟. Observational study. ˍ

Daghighi S, Bahrami N, Tom WJ, Coley N, Seibert TM, Hattangadi-Gluth JA, Piccioni DE, Dale AM, Farid N, McDonald CR.
Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma.
Front Oncol. 2020 Jan 28, 2020;10:24∟. doi: 10.3389/fonc.2020.00024∟. PMID: 32047723∟. Case report. ˍ

Larsson C, Groote I Jr II, Vardal J, Kleppestø M, Odland A, Brandal P, Due-Tønnessen P, Holme SS, Hope TR, Meling TR, Fosse E, Emblem KE, Bjørnerud A.
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Magn Reson Imaging. 2020 Jan 28, 2020;68:106-112∟. doi: 10.1016/j.mri.2020.01.012∟. PMID: 32004711∟. Observational study. ˍ

Fontanilles M, Fontanilles A, Massy N, Rouvet J, Pereira T, Alexandru C, Hanzen C, Basuyau F, Langlois O, Clatot F, Tennevet I, Di Fiore F, Joannides R, Lamoureux F.
Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma.
Fundam Clin Pharmacol. 2020 Jan 29, 2020;10.1111/fcp.12539∟. doi: 10.1111/fcp.12539∟. PMID: 31994757∟. Observational study. ˍ

Breen WG, Anderson SK, Carrero XW, Brown PD, Ballman KV, O'Neill BP, Curran WJ, Abrams RA, Laack NN, Levitt R, Galanis E, Buckner JC, Shaw EG.
Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma.
Neuro Oncol. 2020 Jan 30, 2020;22(6): 830–837∟. doi: 10.1093/neuonc/noaa021∟. PMID: 32002556∟. Interventional study. ˍ

Fujii M, Ichikawa M, Iwatate K, Bakhit M, Yamada M, Kuromi Y, Sato T, Sakuma J, Sato H, Kikuta A, Suzuki Y, Saito K.
Secondary brain tumors after cranial radiation therapy: A single-institution study.
Rep Pract Oncol Radiother. 2020 Jan 30, 2020;25(2):245-249∟. doi: 10.1016/j.rpor.2020.01.009∟. PMID: 32071561∟. Observational study. ˍ

Wang R, Sharma R, Shen X, Laughney AM, Funato K, Clark PJ, Shpokayte M, Morgenstern P, Navare M, Xu Y, Harbi S, Masilionis I, Nanjangud G, Yang Y, Duran-Rehbein G, Hemberg M, Pe'er D, Tabar V.
Adult Human Glioblastomas Harbor Radial Glia-like Cells.
Stem Cell Reports. 2020 Jan 30;14(2):338-350∟. doi: 10.1016/j.stemcr.2020.01.007∟. PMID: 32004492∟. Laboratory investigation. ˍ

Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Harsh GR, Adler JR, Harrahar C, Li G, Hayden Gephart M, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG.
A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.
Neuro Oncol. 2020 Jan 31, 2020;22(8):1182–1189∟. doi: 10.1093/neuonc/noaa019∟. PMID: 32002547∟. Interventional study. ˍ

Das S, Sahgal A, Perry JR.
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Front Oncol. 2020 Jan 31, 2020;10:66∟. doi: 10.3389/fonc.2020.00066∟. PMID: 32083011∟. Comment. ˍ
Refers to: Herrlinger U, et al., Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet. 2019 Feb 16, 2019;393(10172):678-688∟. doi: 10.1016/S0140-6736(18)31791-4∟. PMID: 30782343∟. Interventional study. ˍ

Dissaux G, Basse V, Schick U, El Kabbaj O, Auberger B, Magro E, Kassoul A, Abgral R, Salaun PY, Bourhis D, Querellou S.
Prognostic value of ¹⁸F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma.
Medicine (Baltimore). 2020 Jan 31, 2020;99(5):e19017∟. doi: 10.1097/MD.0000000000019017∟. PMID: 32000446∟. Observational study. ˍ

Kramer K, Donzelli M, Nwora E, Pandit-Taskar N.
Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
J Nucl Med. 2020 Jan 31, 2020:jnumed.119.232678∟. doi: 10.2967/jnumed.119.232678∟. PMID: 32005772∟. Observational study. ˍ